InsidersTradesSigma
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by R. Peters. Director active across 1 company, notably Pharming Group N.V.. Cumulatively, 6 reports have been published. History available since 31 October 2023. The latest transaction was filed on 10 June 2025 (Purchase). Regulator: AFM. All data is openly available.
6 of 6 declarations
R. Peters is a director at Pharming Group N.V.